Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
Public ClinicalTrials.gov record NCT01281657. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this observational study is to collect long-term data on safety and effectiveness of fingolimod, particularly including clinical disease and patient outcome related parameters such as relapse and disability, in patients who have participated in prior trials within the fingolimod clinical development program. Furthermore, this study explores the incidence of selected safety related outcomes of fingolimod treatment during follow-up visits within the context of routine medical practice.
Study identification
- NCT ID
- NCT01281657
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 64 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2011
- Primary completion
- Jun 30, 2012
- Completion
- Jun 30, 2012
- Last update posted
- Sep 5, 2012
2011 – 2012
United States locations
- U.S. sites
- 42
- U.S. states
- 22
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| North Central Neurology Associates, PC | Cullman | Alabama | 35058 | — |
| The Research & Education Inst. of Alta Bates Summit Med. Grp | Berkeley | California | 94705 | — |
| Neuro-Therapeutics, Inc. | Pasadena | California | 91105 | — |
| University of California San Francisco | San Francisco | California | 94117 | — |
| Yale Multiple Sclerosis Center | New Haven | Connecticut | 06510 | — |
| Georgetown University/Lombardi Cancer Center | Washington D.C. | District of Columbia | 20007 | — |
| Sunrise Clinical Research, Inc. | Hollywood | Florida | 33021 | — |
| University of Florida | Jacksonville | Florida | 32209 | — |
| University of Miami | Miami | Florida | 33136 | — |
| Neurological Associates | Pompano Beach | Florida | 33060 | — |
| Neurology Clinical Research, Inc. | Sunrise | Florida | 33351 | — |
| AMO Corporation | Tallahassee | Florida | 32308 | — |
| MS Center of Vero Beach | Vero Beach | Florida | 32960 | — |
| South Suburban Neurology | Flossmoor | Illinois | 60422 | — |
| Neurologic Associates, LTD | Palos Heights | Illinois | 60463 | — |
| Mercy Ruan Neurology Clinic Res Ct. | Des Moines | Iowa | 50314 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Mid America Neuroscience Institute | Lenexa | Kansas | 66214 | — |
| University of Maryland | Baltimore | Maryland | 21201 | — |
| Johns Hopkins MS Center | Baltimore | Maryland | 21287 | — |
| Caritas St. Elizabeth's Hospital | Boston | Massachusetts | 02135 | — |
| Springfield Neurology Associates, LLC | Springfield | Massachusetts | 01104 | — |
| Spectrum Health Medical Group, Neurology | Grand Rapids | Michigan | 49525 | — |
| Saint Luke's Hospital | Kansas City | Missouri | 64111 | — |
| The MS Center for Innovation in Care | St Louis | Missouri | 63131 | — |
| University of New Mexico Health Science Center | Albuquerque | New Mexico | 87131 | — |
| Mount Sinai School of Medicine | New York | New York | 10029 | — |
| Island Neurological Associates | Plainview | New York | 11803 | — |
| SUNY - Stony Brook University | Stony Brook | New York | 11794 | — |
| University of Toledo Health Science Campus | Toledo | Ohio | 43614 | — |
| MS Center of Oklahoma | Oklahoma City | Oklahoma | 73120 | — |
| Neurological Associates of Tulsa, Inc | Tulsa | Oklahoma | 74137 | — |
| University of Pennsylvania Health System | Philadelphia | Pennsylvania | 19104 | — |
| Thomas Jerfferson University Hospital | Philadelphia | Pennsylvania | 19107 | — |
| Vanderbilt University | Nashville | Tennessee | 37204 | — |
| University of Texas Medical School | Houston | Texas | 77030 | — |
| Integra Clinical Research | San Antonio | Texas | 78231 | — |
| University of Virginia Health System | Charlottesville | Virginia | 22903 | — |
| Swedish Neuroscience Institute | Seattle | Washington | 98122 | — |
| Dean Foundation | Madison | Wisconsin | 53715 | — |
| University of Wisconsin Madison | Madison | Wisconsin | 53792 | — |
| St. Luke's Medical Center | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01281657, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 5, 2012 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01281657 live on ClinicalTrials.gov.